Vijay Nathoo, a GP in Manchester, has used evidence to improve prescribing to a small number of patients with gastro-oesophageal reflux. The key was repreat prescribing review, plus individual patient contracts aided by a questionnaire designed to look at critical features of the condition. Quality and cost This is something driven by quality issues. The cost benefits just drop out. As an example, it makes the point that higher quality can often lead to reduced costs, though that will not be a rule.
More people can benefit, or can benefit more.
At the other end of the spectrum we have the work at Peterborough . This will have quality and cost implications as well.